Compare Cytokinetics Inc (CYTK) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Mesoblast Limited — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Cytokinetics Inc is far larger — about 4.8× Mesoblast Limited's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| CYTK | MESO | |
|---|---|---|
Market Cap | $10.63B | $2.21B |
Sector | Technology | Technology |
52-Week High | $87.26 | $20.96 |
52-Week Low | $34.31 | $12.88 |
Enterprise Value | $10.74B | $2.21B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
